Two new studies suggest that the diabetes medication Ozempic may double the risk of a rare but serious condition that damages ...

A Danish study has found that semaglutide, which controls blood glucose while ensuring weight loss, is associated with a ...

including nonarteritic anterior ischemic optic neuropathy, neuromyelitis optica, inflammatory optic neuropathies (sarcoid, lupus and giant cell arteritis), infectious optic neuropathies (Lyme ...

Health officials in Europe are reportedly investigating Ozempic and the trendy drug’s possible link to an eye-rotting condition that causes blindness. Health regulators in Europe will investigate ...

A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases ...

In recent developments, health officials in Europe have launched an investigation into the popular weight loss drug Ozempic, ...

A new study has found that semaglutide, the active ingredient in the popular weight loss drugs Ozempic and Wegovy, may be linked to a type of sudden vision loss called non-arteritic anterior ischemic ...

Researchers have established that the application of once-weekly semaglutide in patients with type 2 diabetes (T2D) increases ...

The rare eye condition, referred to as non-arteritic anterior ischemic optic neuropathy, (NAION), is an irreversible disease caused by reduced blood flow to the optic nerve. The resulting ...

NAION is a rare condition that causes a lack of blood flow to part of the optic nerve, which connects the eye to the brain. Without blood flow, the affected areas swell up, stop working correctly ...

The European Medicines Agency said on Wednesday that it would assess the information in the studies to find out if the drug’s key ingredient and an eye condition known as nonarteritic anterior ...